Monitor whether this 'exploration' translates into actual FDA rulemaking or agency directives; demand transparency on which officials proposed this and what scientific evidence they cited.
This scores high on distraction (B=71) due to extreme outrage potential and media-friendliness around banning widely-used medications, yet remains exploratory with no actual policy implementation. Constitutional harm is moderate (A=30) primarily from institutional capture concerns—health officials exploring medically dubious bans suggests ideological override of scientific expertise—but lacks concrete action or irreversible damage. The 'explored' framing maximizes headlines while minimizing accountability.